MA OBAT ECHO®: Mental Health Prescribing for People with Co-Occurring Substance Use Disorder

Tuesday, 11/10/26, 7:30 AM – 9:00 AM ET

Virtual event via Zoom

Credits available

As part of the twice-monthly MA OBAT ECHO® series, Judith Austin, MSN, PMHNP-BC, CARN-AP, will discuss how to strengthen interdisciplinary collaboration in the assessment and treatment of psychiatric conditions among people with co-occurring substance use disorders (SUD); review common psychiatric disorders and clinical presentations encountered in people with SUD; and explain how to apply evidence-informed principles for initiating, monitoring, and educating patients about commonly prescribed psychiatric medications in the context of SUD. The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.

Show details

MA OBAT ECHO®: Outpatient Management of Alcohol Withdrawal

Tuesday, 12/1/26, 7:30 AM – 9:00 AM ET

Virtual event via Zoom

Credits available

As part of the twice-monthly MA OBAT ECHO® series, Stephen Holt, MD, MS, FACP, FASAM, will discuss the identification, assessment, and management of alcohol withdrawal syndrome (AWS) in outpatient settings, including clinical features and risk factors that inform severity and level-of-care decisions. The presentation will also cover evidence-informed management strategies, including pharmacotherapy, criteria for escalation of care, and interdisciplinary coordination to support safe and effective patient care. The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.

Show details

MA OBAT ECHO®: Substance Use Disorder and Nutrition

Tuesday, 12/22/26, 7:30 AM – 9:00 AM ET

Virtual event via Zoom

Credits available

As part of the twice-monthly MA OBAT ECHO® series, Gabrielle Simons, MS, RD, LDN, will describe the relationship between substance use, nutritional status, and common nutritional deficiencies, as well as interdisciplinary approaches to addressing nutritional needs as part of comprehensive substance use disorder care. She will also review practical strategies for identifying nutritional concerns and connecting patients with appropriate nutritional and medical supports. The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.

Show details

MA OBAT ECHO®: Addressing Adulterants in the Drug Supply: Medetomidine

Tuesday, 1/12/27, 7:30 AM – 9:00 AM ET

Virtual event via Zoom

Credits available

As part of the twice-monthly MA OBAT ECHO® series, Michael Lynch, MD, FACEP, FACMT, will develop interdisciplinary strategies for identifying and responding to emerging drug supply adulterants such as medetomidine across clinical and harm reduction settings and describe the emerging role of medetomidine in the illicit drug supply, including its pharmacologic effects and associated clinical risks. He will also apply clinical approaches to recognizing and managing suspected medetomidine exposure, including overdose response, withdrawal considerations, and linkage to ongoing care.

The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.

Show details

MA OBAT ECHO®: Differentiating SUD Induced Psychosis from Primary Psychotic Disorders

Tuesday, 1/26/27, 7:30 AM – 9:00 AM ET

Virtual event via Zoom

Credits available

As part of the twice-monthly MA OBAT ECHO® series, Megan Hudson, MSN, PMHNP-BC, will improve interdisciplinary assessment and care coordination for patients presenting with psychosis in the context of substance use and differentiate substance-induced psychosis from primary psychotic disorders using clinical history, symptom characteristics, and the temporal relationship between substance use and psychotic symptoms. She will also apply evidence-informed approaches to assessment, treatment planning, and follow-up for patients with co-occurring psychosis and substance use disorders.

The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.

Show details

MA OBAT ECHO®: Considerations Around Alcohol-Related Liver Disease

Tuesday, 2/9/27, 7:30 AM – 9:00 AM ET

Virtual event via Zoom

Credits available

As part of the twice-monthly MA OBAT ECHO® series, Robert Lowe, MD, will improve interdisciplinary coordination in the identification and management of alcohol-related liver disease among patients with alcohol use disorder and recognize key risk factors, clinical features, and stages of alcohol-related liver disease relevant to addiction treatment settings. He will also apply evidence-informed strategies for screening, assessment, treatment, and referral for patients with alcohol-related liver disease.

The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.

Show details

MA OBAT ECHO®: Low-Barrier Hepatitis C Care for People Who Use Substances: Practical Strategies to Improve Access, Treatment, and Cure

Tuesday, 2/23/27, 7:30 AM – 9:00 AM ET

Virtual event via Zoom

Credits available

As part of the twice-monthly MA OBAT ECHO® series, Julia Calandra, PharmD, BCACP, will develop interdisciplinary models of low-barrier hepatitis C care that improve coordination between addiction treatment, medical, and harm reduction services and describe principles of low-barrier, person-centered hepatitis C care and their role in reducing disparities among people who use substances. She will also apply practical strategies for integrating hepatitis C screening and treatment into addiction medicine and harm reduction settings, including models such as group care.

The didactic session will be followed by a de-identified patient case presentation from an ECHO® participant, along with recommendations from the panel of experts and attendees.

Show details